DeepMind is preparing to launch its first commercial product and it aims to aid the diagnosis of complex eye diseases.
The renowned Cambridge-based artificial intelligence experts hope their product will become parent company Alphabet’s first medical device.
In a live demonstration, a patient had a retinal scan performed on her eye. DeepMind’s system was able to provide a diagnosis and ‘urgency score’ in just 30 seconds.
The ability to perform such a...